Intertek to Present at SMi Biosimilars and Biobetters Conference
September 24, 2012
Intertek to Present on Biosimilars Strategies
Ashleigh Wake, Biotechnology Programme Manager, Intertek Pharmaceutical Services, will present at the SMi Biosimilars and Biobetters Conference in London, UK from 24th September to 25 September 2012. Alongside speakers who are both developing and distributing follow on biologics, Ashleigh’s talk will focus on the characterization challenges faced by this industry and suitable analytical strategies to achieve regulatory compliance.
This conference aims to further develop ideas and strategies currently debated in the industry. In particular how industry players will face regulatory challenges in approval of follow on biologics, rising development costs, threat from competition and a similar if not bigger challenge to that seen in marketing of innovator drugs.
Related Intertek Services: